Climb Bio (CLYM)
NASDAQ:CLYM
US Market
Holding CLYM?
Track your performance easily

Climb Bio (CLYM) Ownership - Who Owns Climb Bio?

48 Followers

Climb Bio (CLYM) Ownership Overview

8.56%0.87%3.88%3.93%82.76%
3.88% Other Institutional Investors
3.93% ETFs
82.76% Public Companies and
Individual Investors
The ownership structure of Climb Bio (CLYM) stock is a mix of institutional, retail, and individual investors. Approximately 8.68% of the company’s stock is owned by Institutional Investors, 8.56% is owned by Insiders, and 82.76% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 23, 2024
Valerie Morisset
Evp, R&d And Cso
xxxxxxxxxxxxx
$988495
Jul 19, 2024
Valerie Morisset
Evp, R&d And Cso
xxxxxxxxxxxxx
$289492
Jul 17, 2024
Valerie Morisset
Evp, R&d And Cso
xxxxxxxxxxxxx
$356500
Jul 16, 2024
Valerie Morisset
Evp, R&d And Cso
xxxxxxxxxxxxx
$650563

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$157785
Jun 30, 2024
xxxxxxxxxxxxx
$4948965
Jun 30, 2024
xxxxxxxxxxxxx
$223390988

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
31,419,267Institution46.85%119,393,215
5,417,638Insider8.08%20,587,024
1,458,788Institution2.18%5,543,394
1,125,734Institution1.68%4,277,789
696,057Institution1.04%2,645,017
284,431Institution0.42%1,080,838
178,100Insider0.27%676,780
103,907Insider0.15%394,847
91,766Institution0.14%348,711
78,662Institution0.12%298,916

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
284,431Institution0.42%1,080,838
91,766Institution0.14%348,711
78,662Institution0.12%298,916
53,323Institution0.08%202,627
34,012Institution0.05%129,246
17,128Institution0.03%65,086
9,862Institution0.01%37,476
5,185Institution<0.01%19,703
3,040Institution<0.01%11,552
2,618Institution<0.01%9,948

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
899,648Institution1.34%4,579,208
778,641Institution1.16%2,958,836
404,120Institution0.60%2,056,971
261,744Institution0.39%994,627
131,941Institution0.20%671,580
66,580Institution0.10%253,004
19,249Institution0.03%97,977
16,014Institution0.02%60,693
15,071Institution0.02%57,270
13,656Institution0.02%55,443

FAQ

Who Owns Climb Bio (CLYM)?
According to the latest TipRanks data, approximately 3.88% of the company's stock is held by institutional investors, 8.56% is held by insiders, and 82.76% is held by retail investors.
    What percentage of Climb Bio (CLYM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.88% of Climb Bio (CLYM) stock is held by institutional investors.
      What percentage of Climb Bio (CLYM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 82.76% of Climb Bio (CLYM) stock is held by retail investors.
        Who owns the most shares of Climb Bio (CLYM)?
        Peter Kolchinsky owns the most shares of Climb Bio (CLYM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis